Global Tissue Diagnostics Market Size & Share, Sector / Industry Report & Analysis, 2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Tissue Diagnostics Market


The global Tissue Diagnostics market size is projected to reach US$ 6.5 billion by 2026, from US$ 4.43 billion in 2020, at a CAGR of 6.6% during 2021-2026.Increase in worldwide volume of diagnostic tests conducted across hospitals and laboratories has boosted the market. Future growth prospects of tissue diagnostic products are highly dependent on the paradigm shift toward companion diagnostics.

As companion diagnostics development is attaining lucrative pace, the convergence of both the diagnostic and pharmaceutical industry has resulted in the incorporation of tissue diagnostic technologies in several drug development processes, resulting in greater revenue generation for this market. For example, in December 2016, Leica Biosystems signed an agreement with Bayer to develop companion diagnostic tests based on immunohistochemistry and RNA scope for cancer therapies.

Factors such as process standardization for anatomic pathology laboratory and improvement in laboratory workflows are driving industry growth. One of the significant innovations in the market is the inception of automated tissue diagnostics, which has enhanced assay performance and has effectively addressed issues associated with the lesser number of pathologists available for assistance.

In addition to this, investments in histology and cytology and changes pertaining to reimbursement structure are likely to impact the long-term viability of products and their usage. Improved reimbursement scenario would enable pathology equipment manufacturers to step up for development of novel solutions and overcome productivity challenges

However, increase in consolidation among laboratories and hospitals is expected to escalate the pressure on vendors and is anticipated to adversely affect the customer base in this market. This, in turn, would result in high market competition amongst vendors for fewer accounts.

Market Segmentation, Outlook & Viewpoint: Global Tissue Diagnostics Market

Technology Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

Immunohistochemistry

  
Instruments
  
Slide Staining Systems
  
Tissue Microarrays
  
Tissue Processing Systems
  
Slide Scanners
  
Other products
  
Consumables
  
Antibodies
  
Reagents
  
Kits

In Situ Hybridization

  
Instruments
  
Consumables
  
Software

Primary & Special Staining

Digital Pathology and Workflow

  
Whole Slide Imaging
  
Image Analysis Informatics
  
Information Management System Storage & Communication

Anatomic Pathology

  
Instruments
  
Microtomes & Cryostat microtomes
  
Tissue processors
  
Automatic strainers
  
Other products

Consumables

  
Reagents & Antibodies
  
Probes & Kits
  
Others

Application Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  
Breast Cancer
  
Non-Small Cell Lung Cancer
  
Prostate Cancer
  
Gastric Cancer
  
Other Cancers

End-use Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  
Hospitals
  
Research Laboratories
  
Pharmaceutical Organizations
  
CRO

Key Players, Recent Developments & Regional Insights: Global Tissue Diagnostics Market

Tissue analysis provides crucial information that cannot be availed by virtue of conventional molecular assays. Hence, tissue diagnostic testing continues to serve as one of the gold standards for cancer diagnosis and is utilized in cancer prognosis.

Breast cancer accounted for the largest revenue share in the global tissue diagnostics market owing to highest incidence rate. Furthermore, presence of research initiatives carried out for breast cancer is supportive for the attributed share of the segment. Such efforts, coupled with governments pushing to develop effective products for breast cancer diagnosis, have helped build up enough genetic knowledge and momentum in the sector.

However, absence of commercialized diagnostic tests for non-small lung cancer detection other than those done with the help of a biopsy generates enormous untapped growth opportunities for new players in the market. Companies such as Roche and Exosome Diagnostics are developing protocols based on IHC as well as FISH for cancer detection caused by mutations in different genes.

End-use Insights

The dominance of hospitals in the global market can be attributed to the high efficiency of hospitals to integrate novel technologies, coupled with a large volume of procedures carried out for disease diagnosis, monitoring, and treatment.In several hospitals and clinics, physicians have been switching from conventional testing procedures to tissue diagnostic tests. Long turnover time associated with conventional processes is boosting the adoption rate of tissue diagnostic tests as these aid in reducing the timelines.

CROs are expected to witness the fastest growth owing to increasing pressure on pathology laboratories to cater to customer requirements within stipulated timelines. Furthermore, budget constraints faced by small to medium sized laboratories has generated potential avenues for CROs operating in the diagnostics sector.

Regional Insights

North America accounted for the largest revenue share in the global market owing to presence of key participants in U.S. and higher customer accessibility to services in pathology laboratories and hospitals. The market is also driven by higher incidence rate of cancer in this region.

Asian countries are expected serve as a lucrative source of revenue during the forecast period and the region is expected to emerge as the second largest market, following North America, in the foreseeable future. This is due to the presence of several potential subjects in the region, along with improvements in spending power of customers.

Tissue Diagnostics Market Share Insights

The fragmented nature of the market can be attributed to presence of a substantial number of large and medium-to-small players in the space. Advent of other diagnostic modes such as liquid biopsy has compelled market participants to expand their product portfolio.

For example, in March 2017, Fimmic Oy (Fimmic) launched the WebMicroscope Platform, a cloud-based image analysis solution that embraces deep learning AI for analysis of digital pathology samples. The primary objective behind the introduction of novel products by companies is to reinforce their respective market presence.

Key Insights Covered: Global Tissue Diagnostics Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Tissue Diagnostics industry.
2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Tissue Diagnostics industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Tissue Diagnostics industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Tissue Diagnostics industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Tissue Diagnostics industry.

Research Methodology: Global Tissue Diagnostics Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other